Clinical course and cardiovascular outcomes in patients with the long-chain 3-hydroxyacyl-coenzyme A dehydrogenase deficiency

MeSH terms

• Adolescent
• Arrhythmias, Cardiac / diagnosis
• Arrhythmias, Cardiac / etiology*
• Arrhythmias, Cardiac / mortality
• Arrhythmias, Cardiac / therapy
• Cardiomyopathies / complications*
• Cardiomyopathies / diet therapy
• Cardiomyopathies / genetics
• Cardiomyopathies / mortality
• Cardiomyopathy, Dilated / diagnostic imaging
• Cardiomyopathy, Dilated / etiology*
• Cardiomyopathy, Dilated / mortality
• Cardiomyopathy, Dilated / therapy
• Cardiomyopathy, Hypertrophic / diagnostic imaging
• Cardiomyopathy, Hypertrophic / etiology*
• Cardiomyopathy, Hypertrophic / mortality
• Cardiomyopathy, Hypertrophic / therapy
• Child
• Child, Preschool
• Diet, Fat-Restricted
• Female
• Genetic Predisposition to Disease
• Humans
• Infant
• Lipid Metabolism, Inborn Errors / complications*
• Lipid Metabolism, Inborn Errors / diet therapy
• Lipid Metabolism, Inborn Errors / genetics
• Lipid Metabolism, Inborn Errors / mortality
• Male
• Mitochondrial Myopathies / complications*
• Mitochondrial Myopathies / diet therapy
• Mitochondrial Myopathies / genetics
• Mitochondrial Myopathies / mortality
• Mitochondrial Trifunctional Protein / deficiency*
• Mitochondrial Trifunctional Protein / genetics
• Mitochondrial Trifunctional Protein, alpha Subunit / genetics
• Mutation
• Nervous System Diseases / complications*
• Nervous System Diseases / diet therapy
• Nervous System Diseases / genetics
• Nervous System Diseases / mortality
• Phenotype
• Rhabdomyolysis / complications*
• Rhabdomyolysis / diet therapy
• Rhabdomyolysis / genetics
• Rhabdomyolysis / mortality
• Risk Factors
• Treatment Outcome
• Triglycerides / administration & dosage